| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 FAT4 PCDHGB3 NOX5 CDHR2 PCDHGA7 DUOX2 DLK1 DNAH7 RYR1 ESYT3 DUOX1 CELSR2 PCDH15 GCA SYT5 PADI6 | 4.92e-05 | 749 | 150 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.61e-05 | 2 | 150 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 5.61e-05 | 2 | 150 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 8.70e-05 | 12 | 150 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | procollagen galactosyltransferase activity | 3.33e-04 | 4 | 150 | 2 | GO:0050211 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 4.31e-04 | 20 | 150 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 5.39e-04 | 187 | 150 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.52e-04 | 5 | 150 | 2 | GO:0106294 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 6.86e-06 | 233 | 147 | 10 | GO:0031345 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | FAT4 PCDHGB3 CDHR2 PCDHGA7 CEACAM1 CELSR2 NECTIN2 PCDH15 IGSF9 | 8.02e-06 | 187 | 147 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 PCDHGB3 CDHR2 PCDHGA7 CEACAM1 IL1RAPL1 TENM4 CELSR2 NECTIN2 PCDH15 IGSF9 | 1.56e-05 | 313 | 147 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | epiboly involved in wound healing | 1.86e-05 | 46 | 147 | 5 | GO:0090505 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of cells | 1.86e-05 | 46 | 147 | 5 | GO:0044319 | |
| GeneOntologyBiologicalProcess | epiboly | 2.07e-05 | 47 | 147 | 5 | GO:0090504 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell migration | 5.05e-05 | 2 | 147 | 2 | GO:1902766 | |
| GeneOntologyBiologicalProcess | negative regulation of cell differentiation | SRSF6 MAP2 SPART DLK1 GDI1 CIT DICER1 CEACAM1 RHOA NCOR2 NFATC2 GORASP1 DACT3 DISP3 PRAMEF26 ULK2 G6PD TBX6 | 5.24e-05 | 875 | 147 | 18 | GO:0045596 |
| GeneOntologyBiologicalProcess | negative regulation of nervous system development | 5.34e-05 | 184 | 147 | 8 | GO:0051961 | |
| GeneOntologyBiologicalProcess | ossification involved in bone maturation | 5.88e-05 | 30 | 147 | 4 | GO:0043931 | |
| GeneOntologyBiologicalProcess | bone maturation | 8.63e-05 | 33 | 147 | 4 | GO:0070977 | |
| GeneOntologyBiologicalProcess | neuron development | HSPG2 FAT4 MAP2 FIGNL2 SPART CLASP2 CSMD3 GDI1 CIT DICER1 RHOA IL1RAPL1 STRN TENM4 CELSR2 MAP1S TMEM132E GORASP1 PCDH15 IGSF9 ULK2 EP300 PLXNB1 TBX6 | 1.05e-04 | 1463 | 147 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | cytokinesis | 1.10e-04 | 204 | 147 | 8 | GO:0000910 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 FAT4 MAP2 FIGNL2 SPART CLASP2 CSMD3 GDI1 CIT DICER1 RHOA IL1RAPL1 STRN CELSR2 MAP1S GORASP1 PCDH15 IGSF9 ULK2 EP300 PLXNB1 TBX6 | 1.14e-04 | 1285 | 147 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.30e-04 | 156 | 147 | 7 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.30e-04 | 156 | 147 | 7 | GO:0010927 | |
| GeneOntologyBiologicalProcess | animal organ maturation | 1.36e-04 | 37 | 147 | 4 | GO:0048799 | |
| GeneOntologyBiologicalProcess | dendrite development | MAP2 CSMD3 CIT RHOA IL1RAPL1 STRN CELSR2 MAP1S GORASP1 IGSF9 | 1.49e-04 | 335 | 147 | 10 | GO:0016358 |
| GeneOntologyBiologicalProcess | cuticle development | 1.51e-04 | 3 | 147 | 2 | GO:0042335 | |
| GeneOntologyBiologicalProcess | negative regulation of developmental process | HSPG2 SRSF6 MAP2 FIGNL2 SPART DLK1 GDI1 CIT DICER1 CEACAM1 RHOA USP2 NCOR2 NFATC2 GORASP1 DACT3 DISP3 PRAMEF26 ULK2 G6PD TBX6 | 1.54e-04 | 1220 | 147 | 21 | GO:0051093 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.86e-04 | 74 | 147 | 5 | GO:0002011 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.91e-04 | 166 | 147 | 7 | GO:0061041 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.13e-04 | 169 | 147 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ILDR2 FAT4 PCDHGB3 CDHR2 PCDHGA7 EMILIN2 FCHO1 CEACAM1 EFR3A RHOA IL1RAPL1 JUP TENM4 CELSR2 NECTIN2 PCDH15 CERCAM IGSF9 EP300 | 2.40e-04 | 1077 | 147 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 2.43e-04 | 122 | 147 | 6 | GO:0061387 | |
| GeneOntologyBiologicalProcess | negative regulation of neurogenesis | 2.46e-04 | 173 | 147 | 7 | GO:0050768 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 MAP2 SPART CLASP2 GDI1 CIT IL1RAPL1 CELSR2 MAP1S GORASP1 PCDH15 IGSF9 ULK2 EP300 PLXNB1 | 3.00e-04 | 748 | 147 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 3.00e-04 | 4 | 147 | 2 | GO:0001998 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | MAP2 CDHR2 SPART CLASP2 GDI1 CEACAM1 RHOA DACT3 ULK2 G6PD EP300 OSGIN1 | 3.52e-04 | 519 | 147 | 12 | GO:0001558 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MAP2 CDHR2 FIGNL2 SPART CSMD3 GDI1 GDI2 CIT RHOA IL1RAPL1 TBC1D10C GORASP1 ULK2 EP300 PLXNB1 TBX6 | 3.60e-04 | 846 | 147 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAP2 CDHR2 FIGNL2 SPART CSMD3 GDI1 GDI2 CIT RHOA IL1RAPL1 TBC1D10C GORASP1 ULK2 EP300 PLXNB1 TBX6 | 4.47e-04 | 863 | 147 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | MAP2 FIGNL2 SPART CSMD3 GDI1 CIT RHOA IL1RAPL1 GORASP1 ULK2 EP300 PLXNB1 TBX6 | 4.48e-04 | 612 | 147 | 13 | GO:0010975 |
| GeneOntologyBiologicalProcess | growth | MAP2 CDHR2 COL27A1 SPART DUOX2 CLASP2 DLK1 GDI1 DICER1 CEACAM1 RHOA TENM4 DACT3 PCDH15 ATM DMBT1 ULK2 G6PD EP300 OSGIN1 | 4.93e-04 | 1235 | 147 | 20 | GO:0040007 |
| GeneOntologyBiologicalProcess | negative regulation of wound healing, spreading of epidermal cells | 4.97e-04 | 5 | 147 | 2 | GO:1903690 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | CDK18 MAP2 SPART GDI1 CIT DICER1 RHOA IL1RAPL1 TENM4 GORASP1 ULK2 EP300 PLXNB1 | 5.45e-04 | 625 | 147 | 13 | GO:0051960 |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.34e-05 | 7 | 154 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 6.20e-05 | 11 | 154 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.03e-05 | 185 | 154 | 8 | GO:0009898 | |
| GeneOntologyCellularComponent | cleavage furrow | 8.67e-05 | 61 | 154 | 5 | GO:0032154 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 2.95e-04 | 18 | 154 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | cytoplasmic side of membrane | 3.13e-04 | 230 | 154 | 8 | GO:0098562 | |
| GeneOntologyCellularComponent | cell division site | 3.13e-04 | 80 | 154 | 5 | GO:0032153 | |
| GeneOntologyCellularComponent | proximal neuron projection | 5.31e-04 | 5 | 154 | 2 | GO:1990769 | |
| Domain | Aspartic_peptidase_N | 1.63e-05 | 7 | 147 | 3 | IPR012848 | |
| Domain | NAD_binding_6 | 1.63e-05 | 7 | 147 | 3 | PF08030 | |
| Domain | FAD_binding_8 | 1.63e-05 | 7 | 147 | 3 | PF08022 | |
| Domain | FAD-bd_8 | 1.63e-05 | 7 | 147 | 3 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.63e-05 | 7 | 147 | 3 | IPR013121 | |
| Domain | A1_Propeptide | 1.63e-05 | 7 | 147 | 3 | PF07966 | |
| Domain | Aspartic_peptidase_A1 | 5.50e-05 | 10 | 147 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 5.50e-05 | 10 | 147 | 3 | IPR033121 | |
| Domain | Asp | 5.50e-05 | 10 | 147 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 5.50e-05 | 10 | 147 | 3 | PS51767 | |
| Domain | DUOX1 | 6.15e-05 | 2 | 147 | 2 | IPR029595 | |
| Domain | RabGDI | 6.15e-05 | 2 | 147 | 2 | IPR000806 | |
| Domain | DUF1220 | 7.53e-05 | 11 | 147 | 3 | PF06758 | |
| Domain | NBPF_dom | 7.53e-05 | 11 | 147 | 3 | IPR010630 | |
| Domain | NBPF | 7.53e-05 | 11 | 147 | 3 | PS51316 | |
| Domain | TIG | 9.82e-05 | 31 | 147 | 4 | PF01833 | |
| Domain | Ferric_reduct | 9.98e-05 | 12 | 147 | 3 | PF01794 | |
| Domain | - | 9.98e-05 | 12 | 147 | 3 | 2.40.70.10 | |
| Domain | ASP_PROTEASE | 9.98e-05 | 12 | 147 | 3 | PS00141 | |
| Domain | Fe3_Rdtase_TM_dom | 9.98e-05 | 12 | 147 | 3 | IPR013130 | |
| Domain | IPT | 1.12e-04 | 32 | 147 | 4 | IPR002909 | |
| Domain | Aspartic_peptidase_AS | 1.29e-04 | 13 | 147 | 3 | IPR001969 | |
| Domain | Glyco_transf_25 | 1.84e-04 | 3 | 147 | 2 | PF01755 | |
| Domain | Glyco_trans_25 | 1.84e-04 | 3 | 147 | 2 | IPR002654 | |
| Domain | MYB_LIKE | 2.21e-04 | 38 | 147 | 4 | PS50090 | |
| Domain | LAM_G_DOMAIN | 2.21e-04 | 38 | 147 | 4 | PS50025 | |
| Domain | Cadherin_CS | 2.23e-04 | 109 | 147 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 2.72e-04 | 113 | 147 | 6 | PS00232 | |
| Domain | Cadherin | 2.72e-04 | 113 | 147 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 2.85e-04 | 114 | 147 | 6 | PS50268 | |
| Domain | - | 2.85e-04 | 114 | 147 | 6 | 2.60.40.60 | |
| Domain | CA | 2.99e-04 | 115 | 147 | 6 | SM00112 | |
| Domain | Peptidase_aspartic_dom | 3.00e-04 | 17 | 147 | 3 | IPR021109 | |
| Domain | Cadherin-like | 3.13e-04 | 116 | 147 | 6 | IPR015919 | |
| Domain | Cadherin | 3.43e-04 | 118 | 147 | 6 | IPR002126 | |
| Domain | GDI | 3.65e-04 | 4 | 147 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 3.65e-04 | 4 | 147 | 2 | IPR018203 | |
| Domain | Fd_Rdtase_FAD-bd | 4.22e-04 | 19 | 147 | 3 | IPR017927 | |
| Domain | FAD_FR | 4.22e-04 | 19 | 147 | 3 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.22e-04 | 19 | 147 | 3 | IPR017938 | |
| Domain | RHO | 4.94e-04 | 20 | 147 | 3 | PS51420 | |
| Domain | CUB | 5.93e-04 | 49 | 147 | 4 | PF00431 | |
| Domain | SANT | 6.40e-04 | 50 | 147 | 4 | SM00717 | |
| Domain | CUB | 6.40e-04 | 50 | 147 | 4 | SM00042 | |
| Domain | - | 7.44e-04 | 52 | 147 | 4 | 2.60.120.290 | |
| Domain | SANT/Myb | 7.44e-04 | 52 | 147 | 4 | IPR001005 | |
| Domain | CUB | 8.00e-04 | 53 | 147 | 4 | PS01180 | |
| Domain | CUB_dom | 1.05e-03 | 57 | 147 | 4 | IPR000859 | |
| Domain | SANT_dom | 1.09e-03 | 26 | 147 | 3 | IPR017884 | |
| Domain | Laminin_G | 1.12e-03 | 58 | 147 | 4 | IPR001791 | |
| Domain | IPT | 1.22e-03 | 27 | 147 | 3 | SM00429 | |
| Domain | SANT | 1.35e-03 | 28 | 147 | 3 | PS51293 | |
| Domain | DUF1220 | 2.14e-03 | 9 | 147 | 2 | SM01148 | |
| Domain | Myb_DNA-binding | 2.60e-03 | 35 | 147 | 3 | PF00249 | |
| Domain | An_peroxidase | 2.66e-03 | 10 | 147 | 2 | PF03098 | |
| Domain | Haem_peroxidase_animal | 2.66e-03 | 10 | 147 | 2 | IPR019791 | |
| Domain | Haem_peroxidase | 2.66e-03 | 10 | 147 | 2 | IPR010255 | |
| Domain | PEROXIDASE_3 | 2.66e-03 | 10 | 147 | 2 | PS50292 | |
| Domain | - | 2.66e-03 | 10 | 147 | 2 | 1.10.640.10 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 9.94e-07 | 11 | 107 | 4 | MM15046 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 4.02e-06 | 15 | 107 | 4 | MM15037 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 4.21e-06 | 5 | 107 | 3 | MM15221 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.11e-05 | 19 | 107 | 4 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 1.38e-05 | 20 | 107 | 4 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.46e-05 | 7 | 107 | 3 | MM15217 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.97e-05 | 24 | 107 | 4 | M2243 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS | 3.45e-05 | 9 | 107 | 3 | M27551 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 6.71e-05 | 11 | 107 | 3 | M39726 | |
| Pathway | REACTOME_SURFACTANT_METABOLISM | 7.39e-05 | 30 | 107 | 4 | M27566 | |
| Pathway | WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION | 2.22e-04 | 16 | 107 | 3 | M40060 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 3.77e-04 | 19 | 107 | 3 | M27493 | |
| Pubmed | 3.36e-12 | 21 | 155 | 7 | 16079250 | ||
| Pubmed | 1.89e-09 | 5 | 155 | 4 | 8543060 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 7.80e-08 | 10 | 155 | 4 | 22973535 | |
| Pubmed | RhoA, RhoB and RhoC have different roles in cancer cell migration. | 8.68e-08 | 3 | 155 | 3 | 23488932 | |
| Pubmed | A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. | 8.68e-08 | 3 | 155 | 3 | 12939257 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7926498 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9561228 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21455714 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 19800305 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 29500478 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24170207 | ||
| Pubmed | RhoA, RhoB and RhoC differentially regulate endothelial barrier function. | 8.68e-08 | 3 | 155 | 3 | 28949796 | |
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 8.68e-08 | 3 | 155 | 3 | 3014868 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 8.68e-08 | 3 | 155 | 3 | 2799289 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 19872561 | ||
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 8.68e-08 | 3 | 155 | 3 | 1968039 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 8.68e-08 | 3 | 155 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 8.68e-08 | 3 | 155 | 3 | 2229438 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 8.68e-08 | 3 | 155 | 3 | 19890696 | |
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 8.68e-08 | 3 | 155 | 3 | 8244094 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21407214 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 6774973 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 6300126 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 19477269 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 8.68e-08 | 3 | 155 | 3 | 22304859 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24004680 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8038355 | ||
| Pubmed | Human pepsinogen A isozymogen patterns in serum and gastric mucosa. | 8.68e-08 | 3 | 155 | 3 | 2227273 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 23034090 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24125879 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8751234 | ||
| Pubmed | Enzyme-linked immunosorbent assay and radioimmunoassay of serum pepsinogen A. | 8.68e-08 | 3 | 155 | 3 | 3554488 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 23521833 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3017318 | ||
| Pubmed | Serum pepsinogen test for early detection of gastric cancer in a European country. | 8.68e-08 | 3 | 155 | 3 | 21989121 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9855083 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9797498 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2478370 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3815274 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 22673745 | ||
| Pubmed | Pepsinogens: physiology, pharmacology pathophysiology and exercise. | 8.68e-08 | 3 | 155 | 3 | 10675278 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 26741994 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3780036 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2901984 | ||
| Pubmed | Assignment of human pepsinogen A locus to the q12-pter region of chromosome 11. | 8.68e-08 | 3 | 155 | 3 | 3839486 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 3467902 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 4586732 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 15642170 | ||
| Pubmed | Genomic structure and evolution of the human pepsinogen A multigene family. | 8.68e-08 | 3 | 155 | 3 | 2892778 | |
| Pubmed | Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. | 8.68e-08 | 3 | 155 | 3 | 27147504 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 24383519 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 1455184 | ||
| Pubmed | Hypomethylation and expression of pepsinogen A genes in the fundic mucosa of human stomach. | 8.68e-08 | 3 | 155 | 3 | 2831884 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 2032552 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 1812762 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7923573 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9061458 | ||
| Pubmed | Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. | 8.68e-08 | 3 | 155 | 3 | 12588289 | |
| Pubmed | Gastric cancer detection using gastric juice pepsinogen and melanoma-associated gene RNA. | 8.68e-08 | 3 | 155 | 3 | 23897256 | |
| Pubmed | An aspartic proteinase expressed in the yolk sac and neonatal stomach of the mouse. | 8.68e-08 | 3 | 155 | 3 | 11566730 | |
| Pubmed | The effect of acute and chronic protein loading on urinary pepsinogen A excretion. | 8.68e-08 | 3 | 155 | 3 | 1956484 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 8540382 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 22992016 | ||
| Pubmed | The role of serum pepsinogen in the detection of gastric cancer. | 8.68e-08 | 3 | 155 | 3 | 20981206 | |
| Pubmed | Gastric chief cell-specific transcription of the pepsinogen A gene. | 8.68e-08 | 3 | 155 | 3 | 8504820 | |
| Pubmed | Detection of pepsinogen in the neonatal lung and stomach by immunohistochemistry. | 8.68e-08 | 3 | 155 | 3 | 21970995 | |
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 20428942 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 9525001 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 7886402 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 17379991 | ||
| Pubmed | 8.68e-08 | 3 | 155 | 3 | 21547904 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | HSPG2 PGA4 FAT4 CDHR2 GALNT7 PTGDS PGA5 GDI2 CEACAM1 ACTR1A NECTIN2 QPCT GCA CAPN5 GGACT ENO2 TNXA G6PD PGA3 | 3.33e-07 | 1070 | 155 | 19 | 23533145 |
| Pubmed | Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. | 3.46e-07 | 4 | 155 | 3 | 10559899 | |
| Pubmed | XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. | 3.46e-07 | 4 | 155 | 3 | 12221096 | |
| Pubmed | Serum pepsinogen I/II ratio is correlated with albuminuria in patients with type 2 diabetes. | 3.46e-07 | 4 | 155 | 3 | 23047493 | |
| Pubmed | Rho GTPase independent regulation of ATM activation and cell survival by the RhoGEF Net1A. | 3.46e-07 | 4 | 155 | 3 | 25486363 | |
| Pubmed | Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development. | 3.46e-07 | 4 | 155 | 3 | 11915945 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 8322031 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 8662891 | ||
| Pubmed | Transcription factor SOX2 up-regulates stomach-specific pepsinogen A gene expression. | 3.46e-07 | 4 | 155 | 3 | 17136346 | |
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 22992742 | ||
| Pubmed | 3.46e-07 | 4 | 155 | 3 | 12698190 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 MGAT4B EP400 MED14 CLASP2 BIRC6 CIT RYR1 NBPF1 MST1R ACTR1A NCOR2 CELSR2 MAP1S PPP1R15B ALKBH6 HECTD1 ULK2 EP300 | 5.41e-07 | 1105 | 155 | 19 | 35748872 |
| Pubmed | FAT4 NBPF12 MED14 CSMD3 NBPF1 DNAAF2 ACTR1A NBPF9 NBPF10 QPCT ADAMTS20 HECTD1 NBPF14 | 5.73e-07 | 513 | 155 | 13 | 25798074 | |
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 8617235 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 15093731 | ||
| Pubmed | 8.63e-07 | 5 | 155 | 3 | 22066020 | ||
| Pubmed | Small GTP-binding proteins and the regulation of the actin cytoskeleton. | 1.72e-06 | 6 | 155 | 3 | 7888179 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 9438836 | ||
| Pubmed | Dissecting the role of Rho-mediated signaling in contractile ring formation. | 1.72e-06 | 6 | 155 | 3 | 16236794 | |
| Pubmed | 1.72e-06 | 6 | 155 | 3 | 19286565 | ||
| Pubmed | RHO binding to FAM65A regulates Golgi reorientation during cell migration. | 3.00e-06 | 7 | 155 | 3 | 27807006 | |
| Pubmed | 7.15e-06 | 9 | 155 | 3 | 15151987 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 1.19e-05 | 170 | 155 | 7 | 23314748 | |
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 1.73e-05 | 180 | 155 | 7 | 30110629 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 33162807 | ||
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 1.97e-05 | 2 | 155 | 2 | 28633507 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 21454503 | ||
| GeneFamily | Neuroblastoma breakpoint family | 3.86e-11 | 23 | 104 | 7 | 662 | |
| GeneFamily | Cadherin related | 1.19e-04 | 17 | 104 | 3 | 24 | |
| GeneFamily | Rho family GTPases | 1.96e-04 | 20 | 104 | 3 | 390 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.44e-04 | 53 | 104 | 4 | 532 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.25e-04 | 181 | 104 | 6 | 694 | |
| GeneFamily | Immunoglobulin like domain containing | 8.73e-04 | 193 | 104 | 6 | 594 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON | 4.74e-06 | 158 | 155 | 8 | M1493 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 1.70e-05 | 54 | 155 | 5 | M4737 | |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | HORMAD2 NBPF12 SRSF6 CDHR2 RBPJL SYNPO2L KCNAB2 CLASP2 CPN1 GALNT7 CSMD3 NBPF1 RHOA HOXB6 DUOX1 ADAMDEC1 NBPF10 | 1.73e-05 | 873 | 155 | 17 | M16009 |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 2.03e-05 | 317 | 155 | 10 | MM956 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 155 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.65e-07 | 197 | 155 | 8 | 300849a922722adcbc068593fc5cc0bef936d9cb | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.83e-07 | 198 | 155 | 8 | a631be84e29c277216d89ec6265bd43e87c1dc86 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.64e-06 | 162 | 155 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 174 | 155 | 7 | 2fbdb62e269acf4447b171700a615e878dde7f9f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 174 | 155 | 7 | 7c52b5d8f1e65e5208c952be341fa155ed0e6e76 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 5.22e-06 | 193 | 155 | 7 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.40e-06 | 194 | 155 | 7 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 5.40e-06 | 194 | 155 | 7 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.77e-06 | 196 | 155 | 7 | d3bd8fab010e76024d7e06aba0ea5df3394f411f | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.77e-06 | 196 | 155 | 7 | 77da6b1bcab45d376eb0368f540e0ed24ce98b42 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.97e-06 | 197 | 155 | 7 | 9993fdea353abeafc009ac87439ad25cedf8f1f6 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.97e-06 | 197 | 155 | 7 | a8b41fffa4e86f2766423392951ff320e821a19a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.97e-06 | 197 | 155 | 7 | bc37b8919f98dc18c2200834405f06823d965d78 | |
| ToppCell | Influenza_Severe-NK|Influenza_Severe / Disease group and Cell class | 5.97e-06 | 197 | 155 | 7 | d0f58ee4c02573d214deb210bb7efd3d6118f267 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.97e-06 | 197 | 155 | 7 | a97c4a9eb89260b0b5745834ccef9d558d857f93 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-06 | 198 | 155 | 7 | efdbac7a3a02bff4ca48841772e0c136556c2b9b | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.17e-06 | 198 | 155 | 7 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | COVID-19_Severe-NK|COVID-19_Severe / disease group, cell group and cell class | 6.17e-06 | 198 | 155 | 7 | 0cb88084eac25604ec8f9b1497fb8d2433f1971c | |
| ToppCell | severe-NK|severe / disease stage, cell group and cell class | 6.17e-06 | 198 | 155 | 7 | cb505077dc5bdf3fdd513bb9032e32bb9644c004 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-NK|Influenza_Severe / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | 04ac14414d550b14dc46d682e7af9dd43982211a | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-NK|URO / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | 741c7bad606c7e4d7db57d89aaf4dcf4232fa82a | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-NK|Int-URO / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | 3ae0f3dc4f6c9e0315155de80967134b2c1b3364 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-NK|Leuk-UTI / Disease, condition lineage and cell class | 6.59e-06 | 200 | 155 | 7 | bb37fed4872e71f413ae7c4aa12586fa31075334 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-06 | 200 | 155 | 7 | bfbd2ccf4b28901aad63d70a382a8247e4458ba6 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.59e-06 | 200 | 155 | 7 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.24e-05 | 146 | 155 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-05 | 149 | 155 | 6 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.39e-05 | 149 | 155 | 6 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-05 | 151 | 155 | 6 | def98dc2a8226295b62de2b7f1b587e03a4f038c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 159 | 155 | 6 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 161 | 155 | 6 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.31e-05 | 163 | 155 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 2.39e-05 | 164 | 155 | 6 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-05 | 167 | 155 | 6 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.83e-05 | 169 | 155 | 6 | e3100eb587005e160bd0b7990fa57ec49765133d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 175 | 155 | 6 | d67c77eee979ad029e7545f383326f0ff77c6e5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 175 | 155 | 6 | 1d1cdbf3221b03e24eae38afd57cbd6736b37a53 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 176 | 155 | 6 | ef0ff02897104e938c8a632357d8f1a6f014e68a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-05 | 176 | 155 | 6 | da0983929fa682a68e536c298a2d7add188b7563 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.66e-05 | 177 | 155 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 3.66e-05 | 177 | 155 | 6 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.28e-05 | 182 | 155 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-05 | 183 | 155 | 6 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.41e-05 | 183 | 155 | 6 | 03649492c37f9b274a1caf3e2132ce2915cf1df5 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.55e-05 | 184 | 155 | 6 | e0beb016823514eebdbfc13beb0807efb4470f08 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.69e-05 | 185 | 155 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.69e-05 | 185 | 155 | 6 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-05 | 186 | 155 | 6 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.97e-05 | 187 | 155 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.12e-05 | 188 | 155 | 6 | 1082861eb9e00409caa06d8b2a7b8e7f5fac94c9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-05 | 188 | 155 | 6 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 190 | 155 | 6 | 1d8e169d2448a34180c415843bb49aa45ed540c5 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 190 | 155 | 6 | e792e42fc49472eaf974eb0905819eb51a1da8e5 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.43e-05 | 190 | 155 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 191 | 155 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 192 | 155 | 6 | 550a6574a93acadb43c449094565c73ca51a0c5c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.76e-05 | 192 | 155 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.76e-05 | 192 | 155 | 6 | b498618505bb1b7ff9574d06875dd272c11bac39 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-NK|ICU-SEP / Disease, Lineage and Cell Type | 5.93e-05 | 193 | 155 | 6 | f110f86db305e41639087f5b1a2dff103c07adf0 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_progenitor_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 194 | 155 | 6 | 0ef63abcfd057079a9a6f8b27404ff521d44845d | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 6.10e-05 | 194 | 155 | 6 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.10e-05 | 194 | 155 | 6 | 335c6c2f3f319d4f19eace62f8826a0f40c130f6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.27e-05 | 195 | 155 | 6 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 6.27e-05 | 195 | 155 | 6 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 195 | 155 | 6 | 98b02beafe1d418442e41f85cbf0c7b194fe5957 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.27e-05 | 195 | 155 | 6 | 9ecae6c26a0d0607d101ccf1c38f0b23c5a256a8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 6.27e-05 | 195 | 155 | 6 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-NK|COVID-19_Severe / Disease group, lineage and cell class | 6.45e-05 | 196 | 155 | 6 | cc1daf12de5765ba4f7002396352404b41df2012 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 196 | 155 | 6 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.45e-05 | 196 | 155 | 6 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.45e-05 | 196 | 155 | 6 | 2849c8f06518c9523093b86167daea4c0b9eda73 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 196 | 155 | 6 | 9b3848dd4256cd6d9a21ef6bfdbd0cb7c0030005 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 196 | 155 | 6 | 78b28b263deaa43590b38597186222c6447ad25f | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.45e-05 | 196 | 155 | 6 | bd251231288c900b23d3a676ceec6ac07d228917 | |
| ToppCell | T_cells-CD56_dim_CD16+_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 6.45e-05 | 196 | 155 | 6 | 07b557b8530c19ca5b31ad2eac00c36ef1939266 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.45e-05 | 196 | 155 | 6 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 196 | 155 | 6 | 3e78e307c9c991c1aadc85c61d401431cf75eaec | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 196 | 155 | 6 | f0566f2ef96584ed6d9247b149218376fb509915 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 196 | 155 | 6 | 9554ac6eb5f381bcde3ba40c32aa3fc340974540 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.64e-05 | 197 | 155 | 6 | 4e141dfb094e10383d815fc7108b11a0584c3a4b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-NK_dim-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.64e-05 | 197 | 155 | 6 | 08286770c0b707a7a4436ea8d4416ddfbfe2dc0c | |
| ToppCell | P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.64e-05 | 197 | 155 | 6 | 2cec938caf6ffd031cea37277071487e59b2c71c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 197 | 155 | 6 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | severe_influenza-NK|World / disease group, cell group and cell class (v2) | 6.64e-05 | 197 | 155 | 6 | 8e86a1ee0418e153d4f0bf291006cffc6cf36f71 | |
| ToppCell | Influenza_Severe-NK|World / Disease group and Cell class | 6.64e-05 | 197 | 155 | 6 | 565d578f7a28a19175d56663bf30c60e0d5e1b22 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.64e-05 | 197 | 155 | 6 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.64e-05 | 197 | 155 | 6 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.64e-05 | 197 | 155 | 6 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | COVID-19_Severe-NK|COVID-19_Severe / Disease condition and Cell class | 6.83e-05 | 198 | 155 | 6 | 742c4d6016cfa48444a5919a885ab8d02cad7e18 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.83e-05 | 198 | 155 | 6 | c54da37aa11f82a68e591d563b3db9121d6b498f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.83e-05 | 198 | 155 | 6 | 72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4 | |
| ToppCell | mild-Lymphocytic-NK_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.83e-05 | 198 | 155 | 6 | dce3c008757786aa6bd4a869456b76b4cbbb1d5b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.83e-05 | 198 | 155 | 6 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 7.32e-06 | 197 | 152 | 9 | 205_UP | |
| Drug | Thiorphan [76721-89-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 7.32e-06 | 197 | 152 | 9 | 6249_UP | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A | 7.62e-06 | 198 | 152 | 9 | 2304_UP | |
| Disease | ulcerative colitis (implicated_via_orthology) | 3.85e-06 | 7 | 143 | 3 | DOID:8577 (implicated_via_orthology) | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 6.13e-06 | 8 | 143 | 3 | DOID:0080377 (implicated_via_orthology) | |
| Disease | Peripheral T-Cell Lymphoma | 1.30e-05 | 10 | 143 | 3 | C0079774 | |
| Disease | serum gamma-glutamyl transferase measurement | CDK18 CPN1 CSMD3 CIT FCHO1 ZNF768 NCOR2 STRN TENM4 CELSR2 MAP1S NECTIN2 FUT2 CSMD1 MMP15 | 3.97e-05 | 914 | 143 | 15 | EFO_0004532 |
| Disease | phenylketonuria (implicated_via_orthology) | 1.39e-04 | 4 | 143 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | melanoma | 2.16e-04 | 248 | 143 | 7 | C0025202 | |
| Disease | mental development measurement | 2.37e-04 | 25 | 143 | 3 | EFO_0008230 | |
| Disease | serum alanine aminotransferase measurement | COL27A1 BCORL1 CPN1 STRN TENM4 CELSR2 CDK2AP1 NECTIN2 KLHL23 FUT2 MMP15 KIAA2012 OSGIN1 | 3.25e-04 | 869 | 143 | 13 | EFO_0004735 |
| Disease | neuropsychological test | 4.11e-04 | 197 | 143 | 6 | EFO_0003926 | |
| Disease | Bladder Neoplasm | 6.15e-04 | 140 | 143 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.35e-04 | 141 | 143 | 5 | C0005684 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 7.15e-04 | 303 | 143 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.21e-04 | 9 | 143 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.76e-03 | 13 | 143 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | Tourette syndrome | 1.85e-03 | 50 | 143 | 3 | EFO_0004895 | |
| Disease | free cholesterol to total lipids in small HDL percentage | 1.96e-03 | 51 | 143 | 3 | EFO_0022285 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.04e-03 | 14 | 143 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | serum metabolite measurement | CYP3A43 COL27A1 GBP1 CIT OLFML3 CELSR2 TREH NECTIN2 PCDH15 UTP3 FUT2 CSMD1 | 2.23e-03 | 945 | 143 | 12 | EFO_0005653 |
| Disease | cancer biomarker measurement | 2.35e-03 | 15 | 143 | 2 | EFO_0005127 | |
| Disease | granulysin measurement | 2.35e-03 | 15 | 143 | 2 | EFO_0008144 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 2.56e-03 | 56 | 143 | 3 | EFO_0022279 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.65e-03 | 118 | 143 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | T-Cell Lymphoma | 2.68e-03 | 16 | 143 | 2 | C0079772 | |
| Disease | taste liking measurement | 2.92e-03 | 388 | 143 | 7 | EFO_0010155 | |
| Disease | free cholesterol in very large HDL measurement | 3.42e-03 | 62 | 143 | 3 | EFO_0022273 | |
| Disease | Malignant Neoplasms | 3.55e-03 | 128 | 143 | 4 | C0006826 | |
| Disease | fish consumption measurement | 3.74e-03 | 64 | 143 | 3 | EFO_0010139 | |
| Disease | Systemic Scleroderma | 3.78e-03 | 19 | 143 | 2 | C0036421 | |
| Disease | obesity (implicated_via_orthology) | 4.04e-03 | 215 | 143 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | allergic rhinitis | 4.07e-03 | 133 | 143 | 4 | EFO_0005854 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 4.08e-03 | 66 | 143 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | breast carcinoma (is_marker_for) | 4.08e-03 | 66 | 143 | 3 | DOID:3459 (is_marker_for) | |
| Disease | interstitial lung disease | 4.26e-03 | 67 | 143 | 3 | EFO_0004244 | |
| Disease | gastric ulcer | 4.61e-03 | 21 | 143 | 2 | EFO_0009454 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.61e-03 | 21 | 143 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGPLYYPTVSTISLG | 116 | Q3KRA9 | |
| SSGADPYVRVYLLPE | 786 | A0FGR9 | |
| PSSIERAYAALGLPY | 461 | Q09472 | |
| SSYVAGPLEYPSASL | 1381 | Q96L91 | |
| VYTEPILGGLSYSLP | 296 | Q6P093 | |
| RSEILFGAPLPNYYS | 396 | Q9P2K9 | |
| LLQTRYGLYSSPFDP | 1491 | Q9NR09 | |
| SSGIILSPNYPEEYG | 591 | Q96PZ7 | |
| RKGTILSPGYPEPYD | 1946 | Q7Z407 | |
| YRPPDVLLGSTEYST | 306 | Q07002 | |
| PAILLDGYSGPAYSD | 31 | P28676 | |
| DPDSGPNSYIEYTLL | 2076 | Q6V0I7 | |
| LDPGAALYLYRGPSA | 271 | Q9BZE3 | |
| PGVLASPELRSYPYA | 491 | Q5H9F3 | |
| DDSLYYKGTPGPAVR | 36 | O15484 | |
| PYSDYLNPRSGGISS | 686 | O60563 | |
| LRDSYQGSVYEDVPP | 816 | Q9HCU4 | |
| ALRPYLGFLDGYSPG | 461 | O43246 | |
| DLDYSLEPYTGLTPE | 731 | Q9NQ90 | |
| RELPDGTFYSTLYLP | 656 | Q9UPY3 | |
| TRLPSGYGLAYRLTP | 256 | P80370 | |
| DPSRYITGDQLGALY | 266 | P09104 | |
| PRYLGPAISSGAIYL | 1871 | O14578 | |
| GSGYSVERLSVPYVP | 671 | Q14156 | |
| IYNLPSELPGSRYDG | 471 | P59510 | |
| DFPPREGYVRYGSLV | 261 | Q9UBG7 | |
| DPHPYRGTAIEYSTG | 316 | Q9ULW6 | |
| GSLEPSDGPYNYDLT | 676 | Q9Y5G6 | |
| RYTLSYTAGPQGSPL | 1416 | P98160 | |
| QPLLIERYPGSPGSY | 71 | Q16769 | |
| PYIYGSRGPTEADEL | 481 | P11413 | |
| GLIPPYGLTADTYID | 261 | Q9NRN5 | |
| YIDGPYGTPTRRIFA | 566 | Q96PH1 | |
| AALTGLDVRPPYAEY | 411 | Q7Z4N8 | |
| NPIGGRYDPSLTFSE | 631 | P49736 | |
| YAPFDGILGLAYPSI | 176 | P0DJD9 | |
| EYTGYRPFLDPSISS | 306 | Q9NRD9 | |
| EYGYRPGATAVPTPL | 771 | O14526 | |
| SIPRGIPLDAAAAYY | 1636 | Q9Y618 | |
| DYGLKPYSPLASLSG | 66 | Q13469 | |
| NYYDREVTPLTSSPG | 286 | O43586 | |
| EYPLGRVLIGSSFYP | 431 | Q6TGC4 | |
| NPYYGGESASITPLE | 36 | P50395 | |
| PVYLDLAYLPSGSSA | 946 | Q66K74 | |
| ANGRDPTSYPSLYED | 406 | P43364 | |
| LRYPRSPDGYLQIGS | 491 | Q9UQ53 | |
| LPYSLAPGREYAGRS | 121 | Q9NVR5 | |
| YPLGPRNEDLSLDYA | 46 | Q7Z5Y7 | |
| ITYLRGLFPESSYGE | 46 | Q8N7B1 | |
| PQPLTSYGLGIPYDR | 451 | P51511 | |
| GTAYSLVAPDEIPYL | 436 | Q8TDD1 | |
| PEYTGYRPFLDPSIS | 311 | Q9NRD8 | |
| QRGSPPILYSFYLDE | 231 | Q6DN72 | |
| ILPSSLDYQYDTPGL | 886 | O43157 | |
| RSYEYDVPPTGTLPL | 626 | Q9NZN1 | |
| NPGLVFSRLSPEYYD | 16 | P22749 | |
| LGYGPESPERLSAVY | 786 | Q0VF49 | |
| ADGQPLTPDEYLTYS | 191 | P32455 | |
| SYDSEGPHGLRYNPR | 136 | Q9BVM4 | |
| SGPELFYVYSDGTRL | 156 | A5LHX3 | |
| ASDPDLGPNGLVSYY | 476 | Q9Y5G1 | |
| YSTPSGYLELPDLGQ | 986 | Q3BBV0 | |
| GYLELPDLGQPYRSA | 991 | Q3BBV0 | |
| PDLGQPYRSAVYSLE | 996 | Q3BBV0 | |
| DGDYPIDTYSDGLRP | 721 | P14923 | |
| IDTYSDGLRPPYPTA | 726 | P14923 | |
| SSPAALAGLRPYTDY | 121 | Q9BQQ3 | |
| LAGLRPYTDYVVGSD | 126 | Q9BQQ3 | |
| DSGIPPYSRASLKGY | 256 | Q13303 | |
| VYSGYRGLSPLDAPE | 851 | Q8ND30 | |
| YAPFDGILGLAYPSI | 176 | P0DJD8 | |
| YAIDVLTTGSYPRLP | 156 | O60244 | |
| FLGQLPLYSSGYADP | 21 | P17509 | |
| DPEYPDDYSQGGTRL | 236 | P05187 | |
| RPPSKDGSYVNLYDS | 296 | Q9NR21 | |
| GILYSILVGTPEDYP | 321 | Q96QU1 | |
| PDGLPSARKLIYYTG | 291 | Q96NE9 | |
| LEIYRSIGEPDSLYG | 2006 | Q13315 | |
| GYLRLPPDVSLDYET | 756 | Q9BYE9 | |
| ERLPLHLYDTPGSTY | 976 | Q9ULT8 | |
| YTEPKLGYTRDSPGF | 2506 | Q9ULT8 | |
| PDYTRESYGVTCLGP | 306 | Q8NBE8 | |
| LPGIYTVSATAPGYD | 381 | P15169 | |
| YGRLGPSEPRGIYAS | 146 | Q96B18 | |
| SIDLYRYIPFGAGPR | 426 | Q9HB55 | |
| SYPSLKPLGGYVADL | 3931 | Q8TD57 | |
| TISPSDTYYRPGANL | 241 | P13688 | |
| YASRPESQALPYGDI | 481 | Q86SF2 | |
| GDTIYLANYTLPDSP | 301 | Q10981 | |
| GYEYLGNSPRLVITP | 1291 | Q8WXX0 | |
| GYNAYLSDRLPLDRP | 121 | Q6P9A2 | |
| RQLLSDYGPPSLGYT | 36 | O14519 | |
| YYLPDGSTIEIGPSR | 241 | P61163 | |
| DPGTPGSERTEALYY | 61 | Q9NX46 | |
| GALRPESYSYPDRLV | 1641 | Q8IZC6 | |
| ESYSYPDRLVLDQGG | 1646 | Q8IZC6 | |
| NPYYGGESSSITPLE | 36 | P31150 | |
| APYDGRYLITATLTP | 946 | Q9BXX0 | |
| LDSPYERPALGGYSD | 71 | A6NMB9 | |
| LYDNAPGYGPIISSL | 201 | O43809 | |
| GYRDPYSSRPLTRGE | 396 | Q8IYK4 | |
| NLGVDLLPGYQDPYS | 366 | Q5T4B2 | |
| LLPGYQDPYSGRTLT | 371 | Q5T4B2 | |
| DDTYGPYSSPSLRIA | 2326 | Q9UGM3 | |
| DLGLPPSPGDTSYYQ | 31 | Q9NQZ2 | |
| IAGALPPDYVDASYS | 2706 | P21817 | |
| LELYPAPRESYGADG | 316 | H0Y7S4 | |
| RGASSFDPLIGSPYL | 106 | Q8N813 | |
| SLYGYGSTVRLPEED | 71 | Q8N108 | |
| EQSILSPSPYEGYRS | 346 | Q9UJX0 | |
| YAPFDGILGLAYPSI | 176 | P0DJD7 | |
| AGQEDYDRLRPLSYP | 61 | P08134 | |
| TGAYLIDRDPTYFGP | 116 | Q14681 | |
| GGSSDPYVRVYLLPD | 141 | O00445 | |
| GSLRSPPDSEAYYGE | 126 | Q9H987 | |
| AGQEDYDRLRPLSYP | 61 | P61586 | |
| AGQEDYDRLRPLSYP | 61 | P62745 | |
| DPYDSYDPSVLRGPL | 551 | O43815 | |
| LEPSLLTGEGGYYLT | 566 | Q13671 | |
| SNPEGYIDSSDYPLL | 286 | Q9BYH1 | |
| GTTAPLSLYSPRDYG | 736 | Q6IEE7 | |
| TPSGYLELPDLGQPY | 886 | P0DPF3 | |
| TPSGYLELPDLGQPY | 961 | Q6P3W6 | |
| PSGYLELPDLGQPYS | 1206 | Q6P3W6 | |
| ELPDLGQPYSSAVYS | 1211 | Q6P3W6 | |
| SGYLELPDLGQPYSS | 1451 | Q6P3W6 | |
| LPDLGQPYSSAVYSL | 1456 | Q6P3W6 | |
| YSTPSGYLELPDLGQ | 1691 | Q6P3W6 | |
| GYLELPDLGQPYSSA | 1696 | Q6P3W6 | |
| PDLGQPYSSAVYSLE | 1701 | Q6P3W6 | |
| TPSGYLELPDLGQPY | 2181 | Q6P3W6 | |
| PSGYLELPDLGQPYS | 2426 | Q6P3W6 | |
| ELPDLGQPYSSAVYS | 2431 | Q6P3W6 | |
| SGYLELPDLGQPYSS | 2671 | Q6P3W6 | |
| LPDLGQPYSSAVYSL | 2676 | Q6P3W6 | |
| YSTPSGYLELPDLGQ | 2911 | Q6P3W6 | |
| GYLELPDLGQPYSSA | 2916 | Q6P3W6 | |
| PDLGQPYSSAVYSLE | 2921 | Q6P3W6 | |
| TPSGYLELPDLGQPY | 3401 | Q6P3W6 | |
| PSGYLELPDLGQPYS | 3646 | Q6P3W6 | |
| ELPDLGQPYSSAVYS | 3651 | Q6P3W6 | |
| YSTPSGYLELPDLGQ | 986 | Q5TAG4 | |
| GYLELPDLGQPYRSA | 991 | Q5TAG4 | |
| PDLGQPYRSAVYSLE | 996 | Q5TAG4 | |
| TPSGYLELPDLGQPY | 696 | Q5TI25 | |
| PSGYLELPDLGQPYS | 691 | A0A087WUL8 | |
| ELPDLGQPYSSAVYS | 696 | A0A087WUL8 | |
| SGYLELPDLGQPYSS | 936 | A0A087WUL8 | |
| LPDLGQPYSSAVYSL | 941 | A0A087WUL8 | |
| YSIPSGYLELPDLGQ | 1176 | A0A087WUL8 | |
| GYLELPDLGQPYSSA | 1181 | A0A087WUL8 | |
| PDLGQPYSSAVYSLE | 1186 | A0A087WUL8 | |
| PSGYLELPDLGQPYS | 1911 | A0A087WUL8 | |
| ELPDLGQPYSSAVYS | 1916 | A0A087WUL8 | |
| SGYLELPDLGQPYSS | 2156 | A0A087WUL8 | |
| LPDLGQPYSSAVYSL | 2161 | A0A087WUL8 | |
| YSTPSGYLELPDLGQ | 2396 | A0A087WUL8 | |
| GYLELPDLGQPYSSA | 2401 | A0A087WUL8 | |
| PDLGQPYSSAVYSLE | 2406 | A0A087WUL8 | |
| TPSGYLELPDLGQPY | 2886 | A0A087WUL8 | |
| PSGYLELPDLGQPYS | 3131 | A0A087WUL8 | |
| ELPDLGQPYSSAVYS | 3136 | A0A087WUL8 | |
| SGYLELPDLGQPYSS | 3376 | A0A087WUL8 | |
| LPDLGQPYSSAVYSL | 3381 | A0A087WUL8 | |
| YSTPSGYLELPDLGQ | 3616 | A0A087WUL8 | |
| GYLELPDLGQPYSSA | 3621 | A0A087WUL8 | |
| PDLGQPYSSAVYSLE | 3626 | A0A087WUL8 | |
| TPSGYLELPDLGQPY | 346 | P0DPF2 | |
| PSGYLELPDLGQPYS | 591 | P0DPF2 | |
| ELPDLGQPYSSAVYS | 596 | P0DPF2 | |
| SGYLELPDLGQPYSS | 836 | P0DPF2 | |
| LPDLGQPYSSAVYSL | 841 | P0DPF2 | |
| YSTPSGYLELPDLGQ | 1076 | P0DPF2 | |
| GYLELPDLGQPYSSA | 1081 | P0DPF2 | |
| PDLGQPYSSAVYSLE | 1086 | P0DPF2 | |
| TPSGYLELPDLGQPY | 1566 | P0DPF2 | |
| PSGYLELPDLGQPYS | 1811 | P0DPF2 | |
| ELPDLGQPYSSAVYS | 1816 | P0DPF2 | |
| SGYLELPDLGQPYSS | 2056 | P0DPF2 | |
| LPDLGQPYSSAVYSL | 2061 | P0DPF2 | |
| YSTPSGYLELPDLGQ | 2296 | P0DPF2 | |
| GYLELPDLGQPYSSA | 2301 | P0DPF2 | |
| PDLGQPYSSAVYSLE | 2306 | P0DPF2 | |
| TPSGYLELPDLGQPY | 2786 | P0DPF2 | |
| PSGYLELPDLGQPYS | 3031 | P0DPF2 | |
| ELPDLGQPYSSAVYS | 3036 | P0DPF2 | |
| SGYLELPDLGQPYSS | 3276 | P0DPF2 | |
| LPDLGQPYSSAVYSL | 3281 | P0DPF2 | |
| YSTPSGYLELPDLGQ | 3516 | P0DPF2 | |
| GYLELPDLGQPYSSA | 3521 | P0DPF2 | |
| PDLGQPYSSAVYSLE | 3526 | P0DPF2 | |
| TPSGYLELPDLGQPY | 4006 | P0DPF2 | |
| PSGYLELPDLGQPYS | 4251 | P0DPF2 | |
| ELPDLGQPYSSAVYS | 4256 | P0DPF2 | |
| SGYLELPDLGQPYSS | 4421 | P0DPF2 | |
| LPDLGQPYSSAVYSL | 4426 | P0DPF2 | |
| YSTPSGYLELPDLGQ | 4586 | P0DPF2 | |
| GYLELPDLGQPYSSA | 4591 | P0DPF2 | |
| PDLGQPYSSAVYSLE | 4596 | P0DPF2 | |
| YSTPSGYLELPDLGQ | 4736 | P0DPF2 | |
| GYLELPDLGQPYSSA | 4741 | P0DPF2 | |
| PDLGQPYSSAVYSLE | 4746 | P0DPF2 | |
| LQPAGSLGSYSYRSP | 96 | P41222 | |
| TSGRDKYGPPVRTEY | 96 | Q13247 | |
| YSYLEGDLPISARPA | 406 | Q5SWA1 | |
| RTPYSDGVLYGSPTA | 106 | O43556 | |
| EGYPLPSITGRLDYA | 231 | Q9Y615 | |
| NPGYPYSDSSSILGE | 561 | O00327 | |
| HLLGPDYTETLYSPR | 96 | O15204 | |
| PGEAETLYNSLEPSY | 286 | O75122 | |
| LYFPSLYDRGISSSP | 21 | Q3C1V1 | |
| LYGYTEEQPDGLSFP | 121 | Q96EP0 | |
| AGEVSAPSYPGYLRI | 236 | Q8N0X7 | |
| PAGLYVDPYELASLR | 86 | Q8TBF5 | |
| DLRYNPGSYSTAIPL | 781 | P10745 | |
| GPPLSGYLRDVTGNY | 356 | Q7RTY0 | |
| LPPYSELELTRGPSY | 591 | Q71H61 | |
| SELSGPGPYRQADRY | 26 | Q8IV04 | |
| VAYGGYSTPEDRRPT | 1321 | Q9HBL0 | |
| PYGGPRPESYSKDVE | 281 | O43280 | |
| GPTRTPYEDGLYLFD | 991 | Q9C0C9 | |
| YRSFLPEKSGYPDIG | 1241 | Q9C0C9 | |
| RSPGYEPRSPGYESE | 131 | Q9H5H4 | |
| YLSYGSGPKRFPLVD | 436 | Q9UHP3 | |
| TPLPIDLYRYDDVSG | 2101 | Q6N022 | |
| ELYPSLGAGYRLGPA | 6 | O95947 | |
| SSFPPALAEGYRYPE | 26 | O95947 | |
| SYAPELGRPKGEYRD | 136 | Q9H9C1 | |
| GLEPSTPYRFLLYGL | 101 | Q16473 | |
| GLYSPRIDPDYVGRV | 71 | Q9P2J2 | |
| GYSTLAQSYPSDLPE | 636 | P11137 | |
| RYVPYGASPPSLEGL | 791 | Q8IYT8 | |
| YRGDDYTATLTLGNP | 141 | Q969M1 | |
| LPSGYGYRPASRENE | 906 | O43314 | |
| TRPRTYGPSSLLDYD | 61 | O75604 | |
| YGPSSLLDYDRGRPL | 66 | O75604 | |
| TPLPILYSGSDYRSG | 1006 | Q04912 | |
| LYSGSDYRSGLALPA | 1011 | Q04912 | |
| LPYISYLVAPGSASG | 1316 | Q562E7 | |
| PLYNYGDGTSETAPR | 1676 | Q562E7 | |
| RLGAEYKAYPAPLTS | 1196 | Q7Z3T8 | |
| SPTDADYEYGSRGPL | 336 | Q66K66 | |
| ISEEISPDGSYRLPY | 711 | Q5VVJ2 | |
| SVRYPPEVSISGYDD | 256 | Q92692 |